Supplementary Table 6 from First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell–Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table 6. Best Overall Response (BOR)
Authors: F. Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, Srin Ranasinghe, Ana Lako, Mariano Severgnini, Emily M. Thrash, Jason L. Weirather, Joanna Baginska, Michael P. Manos, Edward J. Doherty, Alexander Stafford, Heather Daley, Jerome Ritz, Patrick A. Ott, Kathleen L. Pfaff, Scott J. Rodig, Charles H. Yoon, Glenn Dranoff, David J. Mooney
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4411966978